找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Coronary Microvascular Dysfunction; Filippo Crea,Gaetano A. Lanza,Paolo G. Camici Book 2014 The Editor(s) (if applicable) and The Author(s

[復(fù)制鏈接]
樓主: Enkephalin
11#
發(fā)表于 2025-3-23 09:43:17 | 只看該作者
Health promotion in the workplace,d myocardial damage in patients undergoing CABG surgery have included ischemic conditioning and drugs, as adenosine and acadesine, diazoxide, volatile anesthetic agents, anti-inflammatory agents, statins and sodium–hydrogen exchange inhibitors. The results achieved with these forms of treatment are discussed in this chapter.
12#
發(fā)表于 2025-3-23 14:58:45 | 只看該作者
ormation on the prevention and treatment of coronary microva.In the past two decades a number of studies have shown that abnormalities in the function and structure of coronary microcirculation can be detected in several cardiovascular diseases.?On the basis of the clinical setting in which it occur
13#
發(fā)表于 2025-3-23 19:35:06 | 只看該作者
14#
發(fā)表于 2025-3-23 23:14:54 | 只看該作者
15#
發(fā)表于 2025-3-24 05:31:48 | 只看該作者
16#
發(fā)表于 2025-3-24 08:06:23 | 只看該作者
17#
發(fā)表于 2025-3-24 14:15:03 | 只看該作者
Treatment of Primary CMDthis chapter. While the pharmacological approach to acute MVA still waits to be defined, treatment of takotsubo disease is mainly based on the control of hemodynamic state, due to the usual spontaneous improvement of the disease.
18#
發(fā)表于 2025-3-24 16:30:22 | 只看該作者
Treatment of CMD in Obstructive CADcluding pharmacological (e.g., adenosine, nitroprusside) and nonpharmacological (e.g., antiembolic devices, ischemic conditioning) tools. This chapter discusses the main results observed with these interventions in these clinical settings.
19#
發(fā)表于 2025-3-24 19:56:12 | 只看該作者
20#
發(fā)表于 2025-3-25 00:34:01 | 只看該作者
Book 2014to the pathogenesis of myocardial ischemia,?thus becoming a possible therapeutic target.?This book provides an update on coronary?physiology?and a systematic assessment of microvascular abnormalities in cardiovascular diseases,?in the hope that it will assist clinicians in prevention, detection?and management of CMD in their everyday activity..
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-24 19:28
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
涞水县| 华宁县| 华安县| 宜君县| 汝南县| 老河口市| 临安市| 宁化县| 积石山| 寿光市| 阜城县| 北碚区| 中西区| 建瓯市| 建宁县| 安乡县| 竹溪县| 安西县| 崇仁县| 长沙县| 南丹县| 肃宁县| 南城县| 保山市| 电白县| 桂平市| 贞丰县| 石屏县| 靖宇县| 台安县| 舒城县| 逊克县| 怀远县| 酉阳| 邢台市| 新民市| 通榆县| 石狮市| 洪洞县| 新和县| 巴楚县|